查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2032 年神经血管设备市场——按产品、按工艺、按治疗应用、按最终用途和全球预测
市场调查报告书
商品编码
1257999

2023-2032 年神经血管设备市场——按产品、按工艺、按治疗应用、按最终用途和全球预测

Neurovascular Devices Market - By Product, By Process, By Therapeutic Applications, By End-use & Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 462 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于神经血管设备的不断创新，预计从 2023 年到 2032 年，神经血管设备市场将出现显着增长。

近年来，神经技术通过闭环治疗控制系统更有效地发展，以最佳空间分辨率提供刺激以获得更好的临床结果。

预计市场巨头持续推出的产品和营销策略将影响未来几年的整体商业环境。 例如，2022 年，美敦力公司宣布推出美敦力神经血管合作实验室平台，该平台旨在推动中风治疗和护理领域的创新。

神经血管设备行业按产品、工艺、治疗应用、最终用途和地理区域进行细分。

在产品的基础上，神经血栓切除术设备领域将从 2023 年到 2032 年获得发展势头。 该细分市场的增长可归因于全球急性缺血性中风发病率的增加。 据世界卫生组织统计，全球每年约有1500万人可能患中风。 神经血栓切除术也已成为急性缺血性中风最优选的治疗方法之一，因为它提供了更好的结果并降低了患者死亡率。

考虑到这一过程，预计神经血栓切除术领域在 2023 年至 2032 年期间的复合年增长率将超过 6%。 增强神经血栓切除术的产品进步将在预测期内推动该细分市场的增长。

在治疗应用方面，狭窄领域在 2022 年的价值超过 5.67 亿美元。 颅内狭窄支持脑动脉变窄。 预计到 2032 年，椎管狭窄发病率的增加将积极推动节段扩张。 例如，多项使用国际疾病分类代码的研究表明，2022 年椎管狭窄的患病率在 7% 到 23% 之间。

到 2032 年，最终用户预计诊所的复合年增长率将超过 6%。 这一细分市场的扩张可归因于越来越多的患者涌入诊所治疗神经血管疾病，如动脉瘤和出血性中风，以及寻求具有成本效益的初级保健。 此外，一些诊所引进了最先进的神经血管设备，这将推动市场发展。

按地区划分，2022 年欧洲神经血管器械市场将占据 29.5% 以上的市场份额。 该地区的市场增长将来自德国、英国和法国等国家日益增加的慢性神经系统疾病负担。 根据一项研究，神经系统疾病在欧盟排名第三，仅次于 CVD 和癌症，2020 年的患病率超过 13%。 此外，整个行业都将受益于该地区行业领先参与者的存在。

内容

第一章调查方法及范围

第 2 章执行摘要

第 3 章：神经血管设备的行业洞察

  • 行业格局，2018-2032 年版
  • 影响行业的因素
    • 司机
      • 北美脑动脉瘤和缺血性中风的增加
      • 对微创手术的需求不断增长
      • 神经血管治疗技术进展
      • 政府为实现全球医疗保健基础设施现代化所做的努力
    • 行业潜在的风险和挑战
      • 需要设计更有效、更便宜的治疗方法
      • 新兴经济体中与神经血管设备商业化相关的挑战
  • 增长分析
    • 按产品分类
    • 按流程
    • 通过治疗用途
    • 按最终用途
  • COVID-19 影响分析
  • 技术概况
  • 供应链分析
  • 监管和赎回状态
  • 波特分析
  • PESTEL 分析

第四章竞争格局

  • 介绍
  • 公司矩阵分析
  • 2021 年创新领导者竞争分析
    • 强生公司
    • 美敦力
    • 史赛克
    • 泰尔茂公司
  • 战略仪表板
  • 竞争对手定位矩阵
  • 战略视角矩阵

第 5 章神经血管设备市场：按产品分类

  • 主要产品趋势
  • 栓塞线圈
  • 颈动脉支架
  • 颅内支架
  • 导管
  • 栓塞保护装置
  • 分流器
  • 神经取栓装置
  • 内环装置
  • 气球系统
  • 支架回收器
  • 导丝
  • 其他

第 6 章神经血管设备市场：按流程

  • 主要流程趋势
  • 神经血栓切除术
  • 脑血管造影
  • 颈动脉内膜切除术 (CEA)
  • 支架植入术
  • 显微手术夹闭
  • 捲绕
  • 流量潜水员
  • 其他

第 7 章神经血管设备市场：按治疗用途分类

  • 主要治疗应用的趋势
  • 脑动脉瘤
  • 狭窄
  • 缺血性中风
  • 其他

第 8 章神经血管设备市场：按最终用途分类

  • 主要的最终用户趋势
  • 医院
  • 门诊手术中心
  • 诊所
  • 其他

第 9 章神经血管设备市场：按地区

  • 主要区域趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
    • 俄罗斯
    • 土耳其人
    • 荷兰
    • 比利时
    • 奥地利
    • 瑞士
    • 波兰
    • 捷克共和国
    • 匈牙利
    • 葡萄牙
    • 希腊
    • 罗马尼亚
    • 保加利亚
    • 丹麦
    • 瑞典
    • 挪威
    • 芬兰
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 新加坡
    • 香港
    • 台湾
    • 印度尼西亚
    • 柬埔寨
    • 菲律宾
    • 越南
    • 马来西亚
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 沙特阿拉伯
    • 南非
    • 阿联酋

第十章公司简介

  • Asahi Intecc CO., LTD.
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Medix Corp.
  • LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker
  • Terumo Corporation
简介目录
Product Code: 794

Neurovascular Devices Market is anticipated to depict strong growth during 2023-2032, owing to the constant technological innovations across neurovascular devices. In recent times, neurotechnologies have evolved to be more effective with closed-loop therapeutic control systems that deliver stimulation with optimal spatial resolution for better clinical outcomes.

Ongoing product launches and marketing strategies by leading market behemoths is speculated to influence the overall business landscape through the coming years. For instance, Medtronic plc in 2022, launched Medtronic Neurovascular Co-Lab Platform developed to expedite the innovation in stroke treatment and care.

Overall, the neurovascular devices industry is segmented in terms of product, process, therapeutic application, end-use, and region.

Based on the product, the neurothrombectomy devices segment will gain momentum from 2023 to 2032. The segmental growth will be attributed to the rising incidences of acute ischemic stroke globally. As per the WHO statistics, approximately 15 million people are likely to suffer from stroke each year globally. In addition, the neurothrombectomy procedure offers better outcomes and lowers the mortality rate in patients making it one of the most preferred treatments for acute ischemic stroke.

Considering the process, the neurothrombectomy procedure segment will depict over 6% CAGR between 2023-2032. Increasing product advancements offering enhanced neurothrombectomy procedures will favor segmental growth over the forecast period.

By therapeutic application, the stenosis segment was valued at over USD 567 million in 2022. Intracranial stenosis supports narrowing of a brain artery. Increasing incidences of spinal stenosis will positively stimulate segment expansion by 2032. For instance, several studies using the International Classification of Diseases codes revealed that the prevalence of spinal stenosis was between 7% and 23% in 2022.

In terms of end-user, the clinics segment is slated to exhibit over 6% CAGR through 2032. The segmental expansion would be ascribed to the growing patient influx in clinics for neurovascular illness treatments such as aneurysms and hemorrhagic strokes and cost-effective primary care. Also, several clinics are being outfitted with cutting-edge neurovascular equipment, which will fuel the market development.

Regionally, Europe neurovascular devices market held over 29.5% market share in 2022. The regional market growth would come from the rising burden of chronic neurological disorders across countries such as Germany, the UK, and France. As per a study, neurological disorders in the EU ranked third after CVDs and cancers depicting more than 13% prevalence in 2020. In addition, the presence of the leading industry participants across the region will benefit the overall industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope and definitions
  • 1.3 Base estimates and working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Neurovascular devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Process trends
    • 2.1.4 Therapeutic application trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Neurovascular Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of brain aneurysm and ischemic strokes in North America
      • 3.2.1.2 Rising demand for minimally invasive surgical procedures
      • 3.2.1.3 Technological advancement in neurovascular treatments
      • 3.2.1.4 Government initiatives to modernize healthcare infrastructure across the globe
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Need for designing more effective and low-cost treatments
      • 3.2.2.2 Challenges involved in commercialization of neurovascular devices across developing and underdeveloped economies
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By process
    • 3.3.3 By therapeutic application
    • 3.3.4 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Technology landscape
  • 3.6 Supply chain analysis
  • 3.7 Regulatory and reimbursement landscape
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of innovation leaders, 2021
    • 4.3.1 Johnson & Johnson Inc
    • 4.3.2 Medtronic
    • 4.3.3 Stryker
    • 4.3.4 Terumo Corporation
  • 4.4 Strategy dashboard
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic outlook matrix

Chapter 5 Neurovascular Devices Market, By Product

  • 5.1 Key product trends
  • 5.2 Embolic coils
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.3 Carotid stents
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.4 Intracranial stents
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.5 Catheters
    • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.5.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.6 Embolic protection devices
    • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.6.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.7 Flow diverters
    • 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.8 Neurothrombectomy devices
    • 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.8.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.9 Intrasaccular devices
    • 5.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.9.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.10 Balloon systems
    • 5.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.10.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.11 Stent retrievers
    • 5.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.11.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.12 Guidewires
    • 5.12.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.12.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.13 Others
    • 5.13.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.13.2 Market estimates and forecast, 2018 - 2032 (000' Units)

Chapter 6 Neurovascular Devices Market, By Process

  • 6.1 Key process trends
  • 6.2 Neurothrombectomy procedure
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Cerebral angiography technique
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Carotid endarterectomy (CEA)
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 Stenting
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.6 Microsurgical clipping
    • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.7 Coiling
    • 6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.8 Flow diversion
    • 6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.9 Others
    • 6.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Neurovascular Devices Market, By Therapeutic Application

  • 7.1 Key therapeutic application trends
  • 7.2 Brain aneurysm
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Stenosis
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.4 Ischemic stroke
    • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.5 Others
    • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Neurovascular Devices Market, By End-use

  • 8.1 Key end-use trends
  • 8.2 Hospitals
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Ambulatory surgical centers
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Clinics
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.5 Others
    • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Neurovascular Devices Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 UK
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Russia
    • 9.3.7 Turkey
    • 9.3.8 Netherlands
    • 9.3.9 Belgium
    • 9.3.10 Austria
    • 9.3.11 Switzerland
    • 9.3.12 Poland
    • 9.3.13 Czech Republic
    • 9.3.14 Hungary
    • 9.3.15 Portugal
    • 9.3.16 Greece
    • 9.3.17 Romania
    • 9.3.18 Bulgaria
    • 9.3.19 Denmark
    • 9.3.20 Sweden
    • 9.3.21 Norway
    • 9.3.22 Finland
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Singapore,
    • 9.4.7 Hong Kong
    • 9.4.8 Taiwan,
    • 9.4.9 Indonesia
    • 9.4.10 Cambodia
    • 9.4.11 Philippines
    • 9.4.12 Vietnam,
    • 9.4.13 Malaysia
    • 9.4.14 Thailand
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 MEA
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Asahi Intecc CO., LTD.
  • 10.2 Integer Holdings Corporation
  • 10.3 Johnson & Johnson Services, Inc.
  • 10.4 Kaneka Medix Corp.
  • 10.5 LivaNova PLC
  • 10.6 Medtronic
  • 10.7 MicroPort Scientific Corporation
  • 10.8 Penumbra, Inc.
  • 10.9 Stryker
  • 10.10 Terumo Corporation